Klasther Biopharma
Biotechnology Research • 
Turin, Piedmont, Italy • 1-10 Employees
Company overview
| Headquarters | Via Nizza, 52, Molecular Biotechnology Center, Turin, Piedmont 10126, IT |
| NAICS | 541714 |
| Keywords | Biotechnology, Oncology, Antibody-Drug Conjugates, Cancer Metabolism, Targeted Therapy Of Cancer |
| Founded | 2024 |
| Employees | 1-10 |
Key Contact at Klasther Biopharma
Giuseppe Ferrauto
Founder and CTO (Chief Technology Officer)
About Klasther Biopharma
Klasther Biopharma is an innovative biotech startup that develops Antibody-Drug Conjugates for cancer treatment. It leverages on a revolutionary principle that allows the antibody to distinguish between normal and cancer cells, thus delivering the cytotoxic payload specifically to the tumor.
$
Klasther Biopharma revenue & valuation
| Annual revenue | $342,220 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,100,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
C-Suite
Employees by Department
Klasther Biopharma has 1 employees across 1 departments.
Departments
Number of employees
Funding Data
Klasther Biopharma has never raised funding before.
Canada
United States
Mexico
India
France
Australia
United KingdomFrequently asked questions
Klasther Biopharma is located in Turin, Piedmont, IT.
Klasther Biopharma was founded in 2024, making it 2 years old. The company has established itself as a significant player in its industry over this time.
Klasther Biopharma has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
